Geode Capital Management, LLC Alkermes Plc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,818,649 shares of ALKS stock, worth $135 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,818,649
Previous 3,873,927
1.43%
Holding current value
$135 Million
Previous $108 Million
1.28%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$653 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$433 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$311 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$267 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.8B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...